Requadt Scott 4
4 · Talaris Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Award
Common Stock
2021-12-31$13.00/sh+1,470$19,110→ 451,236 total - Award
Stock Option (Right to Buy)
2022-02-01+500,000→ 500,000 totalExercise: $9.10Exp: 2032-01-31→ Common Stock (500,000 underlying)
Holdings
- 449,766(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]These shares were acquired by the reporting individual under the issuer's 2021 Employee Stock Purchase Plan ("ESPP") in a transaction exempt under Rule 16b-3(c).
- [F2]These shares are held by Requadt Family Limited Partnership. The reporting person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.
- [F3]The shares underlying this option shall vest as follows: 25% shall vest on February 1, 2023; and the remaining shall vest in 36 equal monthly installments thereafter.